A new analysis of global pharmacovigilance data indicates that while reports of psychiatric distress are common among users ...

The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials ...

Ottawa, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The global pharmacovigilance outsourcing market size is expected to be worth over USD 12.12 billion by 2034, increasing from USD 5.75 billion in 2025. The ...

Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Pharmacovigilance - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Pharmacovigilance was ...

Beena Wood, Qinecsa, saw 2025 as an AI superposition in which pharmacovigilence needed better data foundations and regulation ...

A specialist meeting for drug safety and pharmacovigilance professionals focused on strengthening patient safety and ...

The "Advanced Veterinary Pharmacovigilance Training Course (May 21st - May 22nd, 2026)" has been added to ResearchAndMarkets.com's offering. The purpose of this seminar is to provide a comprehensive, ...

The World Health Organization defines pharmacovigilance (PV) as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other ...

Regulators are tightening up on post-marketing monitoring of biological medicines to detect deficiencies caused by manufacturing problems, particularly those stemming from post-authorization changes ...

The life sciences industry may be limiting its options if safety takes a back seat to efficacy in trial design and product development. In the interests of innovation and commercial advantage, it is ...